Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Spoon full of sugar

- PMLiVE

NICE launches online GP resource

The UK's National Institute for Health and Clinical Excellence has launched a new online resource specifically for general practice, including a section for supporting GP consortia

DH appoints chair of Monitor

The UK's Department of Health has appointed Dr David Bennett as chair of Monitor, the independent regulator of foundation trusts

- PMLiVE

Politics of healthcare

Lansley needs to ensure his White Paper reforms are yielding dividends before the next election

Celgene’s Vidaza approved by NICE

Following improvements to its patient access scheme, NICE has changed its decision and recommended Vidaza (azacitidine) for the treatment of myelodysplastic syndromes (MDS)

NHS reforms threaten doctors’ education

Reforms to the NHS could have a negative effect on medical education and training in England, according to junior doctor leaders

Drugs access varies across England

Report finds wide differences in patient access to NICE-approved medicines

DH appoints new board members

Dr Catherine Bell and Dr David Heymann are to join the departmental board of the UK's Department of Health as non-executive board members

Lansley: NHS must embrace competition

UK Health Secretary, Andrew Lansley, has said the NHS needs to embrace value-based competition as part of the government’s reform plans

- PMLiVE

Dropping the ball

With the NHS 'transition' in progress, how well is industry coping with all it has to juggle?

GPs could hand flu vaccine control to DH

GPs in England could face losing responsibility for the management of flu vaccines following recent issues with supply

Health and Social Care Bill announced

The coalition government has announced the publication of the first draft for the Health and Social Care Bill 2010-11, detailing potential large-scale reforms to the NHS in England

EMIG responds on Cancer Drugs Fund

UK pharmaceutical industry group urges that new initiative must not be a forerunner to value-based pricing

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links